In the ever-evolving landscape of medical histopathology, the quest for efficiency, standardization, and cost-effectiveness has driven groundbreaking innovations. At the forefront of this revolution is the BxChip® technology by Lumea,…
Simple Summary The current need to reduce costs in research and diagnostic histopathology is fueling the development of new technologies. Tissue microarray (TMA) technology facilitates the simultaneous preparation of multiple…
Due to significant cuts in laboratory reimbursement rates, the Comprehensive Urology pathology lab was looking for ways to maintain the economic viability of their histology laboratory. They decided to test…
Learn how labs are using the Lumea BxChip® to save lab time, increase efficiency, reduce costs, and improve quality for potentially better diagnostic accuracy. Two recent articles praise the BxChip…
Abstract Objectives Current protocols for processing multiple prostate biopsy cores per case are uneconomical and cumbersome. Tissue fragmentation and loss compromise cancer diagnosis. We sought to study an alternate method…
Abstract Introduction and Objectives Due to significant cuts in reimbursement, more efficient histology techniques are needed to maintain the economic viability of the histology laboratory. There is also an increasing…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
